Remove Download Remove Drug Development Remove Marketing
article thumbnail

The Real Cost of Complexity: What Every Drug Developer Needs to Know

PPD

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

article thumbnail

New Report Reveals Trends, Opportunities in Drug Development

PPD

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Survey Uncovers Global Challenges and Opportunities in Drug Development

PPD

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. Applying artificial intelligence (AI) to drug development (e.g., mRNA, drug discovery platforms) ranked as the No.

article thumbnail

Accelerating Global Drug Development Timelines With Ethnobridging

Alta Sciences

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B.

article thumbnail

Optimizing the Market Value of an Asset with Multiple Potential Indications

The Premier Consulting Blog

Research and development (R&D) investment decisions may be the largest risk taken by drug developers. The leadership of the company had chosen its preferred indication but, before engaging institutional investors in order to raise capital, wanted to confirm the value of the two different development programs.

article thumbnail

FSP Engagements Continue to Gain Popularity, Drive Success

PPD

A large majority of drug developers utilize FSP or hybrid FSP/FSO models, half are “heavy users” Heavy users: Those that use FSP or hybrid FSP/FSO models for most of their clinical development outsourcing. Heavy users leverage these models for nearly three-quarters of their outsourcing.

article thumbnail

Generative AI Revolution: A Comparative Analysis

Perficient: Drug Development

Download the Android Studio preview release Canary build (Jelly Fish| 2023.3.1). Alternatively, you can just Download the Sample app from the GitHub and add the API key to the local.properties to run the app. It’s essential to recognize the remarkable capabilities of Generative AI tools on the market.

Packaging 115